Compare BKTI & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKTI | EOLS |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.7M | 304.0M |
| IPO Year | 2000 | 2018 |
| Metric | BKTI | EOLS |
|---|---|---|
| Price | $83.63 | $4.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $74.00 | $17.40 |
| AVG Volume (30 Days) | 23.3K | ★ 870.7K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 446.15 | 25.00 |
| EPS | ★ 2.38 | N/A |
| Revenue | $74,094,000.00 | ★ $266,274,000.00 |
| Revenue This Year | $12.00 | $13.57 |
| Revenue Next Year | $11.30 | $11.39 |
| P/E Ratio | $35.96 | ★ N/A |
| Revenue Growth | ★ 45.42 | 31.76 |
| 52 Week Low | $26.20 | $4.09 |
| 52 Week High | $89.23 | $14.93 |
| Indicator | BKTI | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 35.20 |
| Support Level | $73.89 | $4.09 |
| Resistance Level | $85.06 | $4.99 |
| Average True Range (ATR) | 3.92 | 0.23 |
| MACD | 0.43 | 0.06 |
| Stochastic Oscillator | 84.24 | 27.66 |
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.